Israel Reports Very Few Myocarditis Cases Among 12- to 15-Year-Olds After Booster

January 7, 2022

(Medscape) – Only two cases of myocarditis were reported in Israel among 44,000 youngsters aged 12 to 15 who received a third dose of the Pfizer/BioNtech vaccine, the Health Ministry said on Wednesday. The heart inflammations developed by two male teens were both mild, the ministry said. Studies have shown that while the Pfizer/BioNTech COVID-19 vaccine marginally increases the risk of heart inflammation, the risk is higher among those infected with the coronavirus. (Read More)